<DOC>
	<DOCNO>NCT02174120</DOCNO>
	<brief_summary>To explore application target control infusion etomidate combine propofol maintenance anesthesia brain surgery .</brief_summary>
	<brief_title>The Application Target Controlled Infusion Etomidate Combined With Propofol Maintenance Anesthesia During Brain Surgeries</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Propofol</mesh_term>
	<mesh_term>Etomidate</mesh_term>
	<criteria>Aged 60 80 year Brain surgery Body weight 45 75 kg body mass index 30 kg/m2 American Society Anesthesiology ( ASA ) Physical Status : Ⅰ Ⅱ Expected operation duration 3 5 h Signed informed consent form Serious cardiac , cerebral ( acute stroke , uncontrolled seizure , sever dementia ) , liver , kidney , lung , endocrine disease sepsis History general anesthesia within 24 h operation Long use hormone history adrenal suppression Hyperlipidaemia Long use psychotropic substance Systolic pressure still 90 mm Hg twice give vasopressor agent Suspected abuse narcotic analgesia Patients need use neuromuscular block drug ( except intubation ) Allergy trial drug contraindication Pregnant breastfeed woman Attendance trial past 30 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>